LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 237

Search options

  1. Article ; Online: Severity rating of specific skin lesions in hidradenitis suppurativa: the ptient perspective.

    Thorlacius, Linnea / Riis, Peter Theut / Musaeus, Katrine D / Saunte, Ditte M / Esmann, Solveig / Jemec, Gregor B E / Hansen, Stine Thestrup

    The British journal of dermatology

    2023  Volume 190, Issue 4, Page(s) 579–581

    MeSH term(s) Humans ; Hidradenitis Suppurativa/diagnosis ; Hidradenitis Suppurativa/pathology ; Severity of Illness Index
    Language English
    Publishing date 2023-12-06
    Publishing country England
    Document type Journal Article
    ZDB-ID 80076-4
    ISSN 1365-2133 ; 0007-0963
    ISSN (online) 1365-2133
    ISSN 0007-0963
    DOI 10.1093/bjd/ljad491
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: No effect of the turmeric root phenol curcumin on prednisolone-induced glucometabolic perturbations in men with overweight or obesity.

    Hellmann, Pernille H / Bagger, Jonatan I / Carlander, Katrine R / Hansen, Katrine B / Forman, Julie L / Størling, Joachim / Chabanova, Elizaveta / Holst, Jens / Vilsbøll, Tina / Knop, Filip K

    Endocrine connections

    2023  Volume 12, Issue 4

    Abstract: ... randomised to one of three intervention groups (A) prednisolone placebo+curcumin placebo, (B) prednisolone ...

    Abstract Objectives: Preclinically, curcumin has been shown to protect against glucocorticoid-induced insulin resistance. We evaluated the effect of curcumin administered with prednisolone in healthy overweight or obese men.
    Methods: In a double-blind, parallel-group trial, 24 overweight/obese non-diabetic men were randomised to one of three intervention groups (A) prednisolone placebo+curcumin placebo, (B) prednisolone (50 mg/day)+curcumin placebo or (C) prednisolone and curcumin (400 mg/day). Curcumin or curcumin placebo treatment started 1 day prior to 10-day prednisolone or prednisolone placebo treatment. The primary endpoint was change in prednisolone-induced insulin resistance assessed by homeostatic model assessment of insulin resistance (HOMA2-IR). Other endpoints included anthropometric measurements, magnetic resonance spectroscopy-assessed hepatic fat content, blood pressure, circulating metabolic markers and continuous glucose monitoring measures.
    Results: Baseline characteristics (mean ± s.d): age 44.2 ± 13.7 years, BMI 30.1 ± 3.5 kg/m2, HbAlc 33.3 ± 3.2 mmol/mol, HOMA2-IR 1.10 ± 0.45 and fasting plasma glucose 5.2 ± 0.4 mmol/L. Prednisolone significantly increased HOMA2-IR (estimated treatment difference 0.36 (95% CI 0.16; 0.57)). Co-treatment with curcumin had no effect on HOMA2-IR (estimated treatment difference 0.08 (95% CI -0.13; 0.39)). Prednisolone increased HbAlc, insulin, C-peptide, glucagon, blood pressure, mean interstitial glucose, time spent in hyperglycaemia and glucose variability, but no protective effect of curcumin on any of these measures was observed.
    Conclusions: In this double-blind, placebo-controlled parallel-group study involving 24 overweight or obese men randomised to one of three treatment arms, curcumin treatment had no protective effect on prednisolone-induced insulin resistance or other glucometabolic perturbations.
    Language English
    Publishing date 2023-03-28
    Publishing country England
    Document type Journal Article
    ZDB-ID 2668428-7
    ISSN 2049-3614
    ISSN 2049-3614
    DOI 10.1530/EC-22-0334
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial.

    Kornum, Ditte S / Bertoli, Davide / Kufaishi, Huda / Wegeberg, Anne-Marie / Okdahl, Tina / Mark, Esben B / Høyer, Katrine L / Frøkjær, Jens B / Brock, Birgitte / Krogh, Klaus / Hansen, Christian S / Knop, Filip K / Brock, Christina / Drewes, Asbjørn M

    Diabetologia

    2024  Volume 67, Issue 6, Page(s) 1122–1137

    Abstract: Aims/hypothesis: Diabetic gastroenteropathy frequently causes debilitating gastrointestinal symptoms. Previous uncontrolled studies have shown that transcutaneous vagal nerve stimulation (tVNS) may improve gastrointestinal symptoms. To investigate the ... ...

    Abstract Aims/hypothesis: Diabetic gastroenteropathy frequently causes debilitating gastrointestinal symptoms. Previous uncontrolled studies have shown that transcutaneous vagal nerve stimulation (tVNS) may improve gastrointestinal symptoms. To investigate the effect of cervical tVNS in individuals with diabetes suffering from autonomic neuropathy and gastrointestinal symptoms, we conducted a randomised, sham-controlled, double-blind (participants and investigators were blinded to the allocated treatment) study.
    Methods: This study included adults (aged 20-86) with type 1 or 2 diabetes, gastrointestinal symptoms and autonomic neuropathy recruited from three Steno Diabetes Centres in Denmark. Participants were randomly allocated 1:1 to receive active or sham stimulation. Active cervical tVNS or sham stimulation was self-administered over two successive study periods: 1 week of four daily stimulations and 8 weeks of two daily stimulations. The primary outcome measures were gastrointestinal symptom changes as measured using the gastroparesis cardinal symptom index (GCSI) and the gastrointestinal symptom rating scale (GSRS). Secondary outcomes included gastrointestinal transit times and cardiovascular autonomic function.
    Results: Sixty-eight participants were randomised to the active group, while 77 were randomised to the sham group. Sixty-three in the active and 68 in the sham group remained for analysis in study period 1, while 62 in each group were analysed in study period 2. In study period 1, active and sham tVNS resulted in similar symptom reductions (GCSI: -0.26 ± 0.64 vs -0.17 ± 0.62, p=0.44; GSRS: -0.35 ± 0.62 vs -0.32 ± 0.59, p=0.77; mean ± SD). In study period 2, active stimulation also caused a mean symptom decrease that was comparable to that observed after sham stimulation (GCSI: -0.47 ± 0.78 vs -0.33 ± 0.75, p=0.34; GSRS: -0.46 ± 0.90 vs -0.35 ± 0.79, p=0.50). Gastric emptying time was increased in the active group compared with sham (23 min vs -19 min, p=0.04). Segmental intestinal transit times and cardiovascular autonomic measurements did not differ between treatment groups (all p>0.05). The tVNS was well-tolerated.
    Conclusions/interpretation: Cervical tVNS, compared with sham stimulation, does not improve gastrointestinal symptoms among individuals with diabetes and autonomic neuropathy.
    Trial registration: ClinicalTrials.gov NCT04143269 FUNDING: The study was funded by the Novo Nordisk Foundation (grant number NNF180C0052045).
    MeSH term(s) Humans ; Female ; Male ; Middle Aged ; Double-Blind Method ; Vagus Nerve Stimulation/methods ; Adult ; Aged ; Transcutaneous Electric Nerve Stimulation/methods ; Diabetic Neuropathies/therapy ; Diabetic Neuropathies/physiopathology ; Gastrointestinal Diseases/therapy ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/therapy ; Aged, 80 and over ; Diabetes Mellitus, Type 1/complications ; Diabetes Mellitus, Type 1/therapy ; Treatment Outcome ; Young Adult
    Language English
    Publishing date 2024-03-28
    Publishing country Germany
    Document type Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't ; Multicenter Study
    ZDB-ID 1694-9
    ISSN 1432-0428 ; 0012-186X
    ISSN (online) 1432-0428
    ISSN 0012-186X
    DOI 10.1007/s00125-024-06129-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Healthy brain aging assessed with [

    Andersen, Katrine B / Hansen, Allan K / Knudsen, Karoline / Schacht, Anna Christina / Damholdt, Malene F / Brooks, David J / Borghammer, Per

    Nuclear medicine and biology

    2022  Volume 112-113, Page(s) 52–58

    Abstract: Background: The average human lifespan has increased dramatically over the past century. However, molecular and physiological alterations of the healthy brain during aging remain incompletely understood. Generalized synaptic restructuring may contribute ...

    Abstract Background: The average human lifespan has increased dramatically over the past century. However, molecular and physiological alterations of the healthy brain during aging remain incompletely understood. Generalized synaptic restructuring may contribute to healthy aging and the reduced metabolism observed in the aged brain. The aim of this study was to assess healthy brain aging using [
    Method: Using in vivo PET imaging and the novel synaptic-vesicle-glycoprotein 2A (SV2A) radioligand [
    Results: We found widespread cortical reduction of synaptic density in a cohort of older HC subjects (N = 15) compared with young HC subjects (N = 11). However, no reduction persisted after partial volume correction and corrections for multiple comparison. Our study confirms previously reported synaptic stability during aging. Regional differences in relative [
    Conclusion: In vivo PET using [
    MeSH term(s) Aged ; Brain/diagnostic imaging ; Brain/metabolism ; Fluorodeoxyglucose F18/metabolism ; Glucose/metabolism ; Glycoproteins/metabolism ; Healthy Aging ; Humans ; Positron-Emission Tomography/methods
    Chemical Substances Glycoproteins ; Fluorodeoxyglucose F18 (0Z5B2CJX4D) ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2022-07-08
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1138098-6
    ISSN 1872-9614 ; 0883-2897 ; 0969-8051
    ISSN (online) 1872-9614
    ISSN 0883-2897 ; 0969-8051
    DOI 10.1016/j.nucmedbio.2022.06.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Quadratus lumborum block for total hip arthroplasty: anatomical knowledge is always key for choice of blocks and execution.

    Steingrimsdottir, Gudny / Hansen, Christian K / Dam, Mette / Tanggaard, Katrine B / Nielsen, Martin Vedel / Børglum, Jens

    Regional anesthesia and pain medicine

    2020  Volume 46, Issue 1, Page(s) 92–93

    MeSH term(s) Analgesia ; Arthroplasty, Replacement, Hip/adverse effects ; Humans ; Nerve Block/adverse effects ; Pain Management
    Language English
    Publishing date 2020-05-05
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 1425299-5
    ISSN 1532-8651 ; 1098-7339 ; 0146-521X
    ISSN (online) 1532-8651
    ISSN 1098-7339 ; 0146-521X
    DOI 10.1136/rapm-2019-101222
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Discovery of Potent Tetrazole Free Fatty Acid Receptor 2 Antagonists.

    Valentini, Alice / Schultz-Knudsen, Katrine / Højgaard Hansen, Anders / Tsakoumagkou, Argyro / Jenkins, Laura / Christensen, Henriette B / Manandhar, Asmita / Milligan, Graeme / Ulven, Trond / Rexen Ulven, Elisabeth

    Journal of medicinal chemistry

    2023  Volume 66, Issue 9, Page(s) 6105–6121

    Abstract: The free fatty acid receptor 2 (FFA2), also known as GPR43, mediates effects of short-chain fatty acids and has attracted interest as a potential target for treatment of various metabolic and inflammatory diseases. Herein, we report the results from ... ...

    Abstract The free fatty acid receptor 2 (FFA2), also known as GPR43, mediates effects of short-chain fatty acids and has attracted interest as a potential target for treatment of various metabolic and inflammatory diseases. Herein, we report the results from bioisosteric replacement of the carboxylic acid group of the established FFA2 antagonist CATPB and SAR investigations around these compounds, leading to the discovery of the first high-potency FFA2 antagonists, with the preferred compound TUG-2304 (
    MeSH term(s) Fatty Acids, Nonesterified ; Propionates ; Receptors, Cell Surface/antagonists & inhibitors ; Receptors, Cell Surface/chemistry ; Receptors, G-Protein-Coupled/metabolism
    Chemical Substances Fatty Acids, Nonesterified ; Propionates ; Receptors, Cell Surface ; Receptors, G-Protein-Coupled ; FFA2R protein, human
    Language English
    Publishing date 2023-05-02
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.2c01935
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Once-weekly subcutaneous semaglutide treatment for persons with type 2 diabetes: Real-world data from a diabetes out-patient clinic.

    Hansen, Katrine B / Svendstrup, Mathilde / Lund, Asger / Knop, Filip K / Vilsbøll, Tina / Vestergaard, Henrik

    Diabetic medicine : a journal of the British Diabetic Association

    2021  Volume 38, Issue 10, Page(s) e14655

    Abstract: Aims: The once-weekly administered glucagon-like peptide 1 (GLP-1) receptor agonist (GLP-1RA) semaglutide, has, in clinical trials, demonstrated significant reductions in glycated haemoglobin A: Methods: This retrospective observational cohort study ... ...

    Abstract Aims: The once-weekly administered glucagon-like peptide 1 (GLP-1) receptor agonist (GLP-1RA) semaglutide, has, in clinical trials, demonstrated significant reductions in glycated haemoglobin A
    Methods: This retrospective observational cohort study included persons with type 2 diabetes (n = 119) on a broad range of antidiabetic medicine: GLP-1RA naïve persons (n = 37) and GLP-1RA-experienced persons (n = 82). Person characteristics at inclusion: age [median (quartiles)]: 65 (57, 72) years; body weight 99 (86, 118) kg; body mass index (BMI) 33 (29, 38) kg/m²; HbA
    Results: After 12 months, the reductions in HbA
    Conclusion: We observed effects of semaglutide once weekly on HbA
    MeSH term(s) Aged ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/drug therapy ; Drug Administration Schedule ; Female ; Glucagon-Like Peptide 1/agonists ; Glucagon-Like Peptides/administration & dosage ; Glucagon-Like Peptides/pharmacology ; Glycated Hemoglobin A/metabolism ; Humans ; Injections, Subcutaneous ; Male ; Middle Aged ; Outpatients ; Retrospective Studies ; Treatment Outcome
    Chemical Substances Glycated Hemoglobin A ; hemoglobin A1c protein, human ; semaglutide (53AXN4NNHX) ; Glucagon-Like Peptides (62340-29-8) ; Glucagon-Like Peptide 1 (89750-14-1)
    Language English
    Publishing date 2021-08-04
    Publishing country England
    Document type Journal Article ; Observational Study
    ZDB-ID 605769-x
    ISSN 1464-5491 ; 0742-3071 ; 1466-5468
    ISSN (online) 1464-5491
    ISSN 0742-3071 ; 1466-5468
    DOI 10.1111/dme.14655
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Connecting the αα-hubs: same fold, disordered ligands, new functions.

    Staby, Lasse / Bugge, Katrine / Falbe-Hansen, Rasmus Greve / Salladini, Edoardo / Skriver, Karen / Kragelund, Birthe B

    Cell communication and signaling : CCS

    2021  Volume 19, Issue 1, Page(s) 2

    Abstract: Background: Signal fidelity depends on protein-protein interaction-'hubs' integrating cues from large interactomes. Recently, and based on a common secondary structure motif, the αα-hubs were defined, which are small α-helical domains of large, modular ... ...

    Abstract Background: Signal fidelity depends on protein-protein interaction-'hubs' integrating cues from large interactomes. Recently, and based on a common secondary structure motif, the αα-hubs were defined, which are small α-helical domains of large, modular proteins binding intrinsically disordered transcriptional regulators.
    Methods: Comparative structural biology.
    Results: We assign the harmonin-homology-domain (HHD, also named the harmonin N-terminal domain, NTD) present in large proteins such as harmonin, whirlin, cerebral cavernous malformation 2, and regulator of telomere elongation 1 to the αα-hubs. The new member of the αα-hubs expands functionality to include scaffolding of supra-modular complexes mediating sensory perception, neurovascular integrity and telomere regulation, and reveal novel features of the αα-hubs. As a common trait, the αα-hubs bind intrinsically disordered ligands of similar properties integrating similar cellular cues, but without cross-talk.
    Conclusion: The inclusion of the HHD in the αα-hubs has uncovered new features, exemplifying the utility of identifying groups of hub domains, whereby discoveries in one member may cross-fertilize discoveries in others. These features make the αα-hubs unique models for decomposing signal specificity and fidelity. Using these as models, together with other suitable hub domain, we may advance the functional understanding of hub proteins and their role in cellular communication and signaling, as well as the role of intrinsically disordered proteins in signaling networks. Video Abstract.
    MeSH term(s) Intrinsically Disordered Proteins/chemistry ; Ligands ; Protein Interaction Domains and Motifs ; Protein Interaction Mapping
    Chemical Substances Intrinsically Disordered Proteins ; Ligands
    Language English
    Publishing date 2021-01-06
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1478-811X
    ISSN (online) 1478-811X
    DOI 10.1186/s12964-020-00686-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Dose-Response of Myofibrillar Protein Synthesis To Ingested Whey Protein During Energy Restriction in Overweight Postmenopausal Women: A Randomized, Controlled Trial.

    Larsen, Mads S / Witard, Oliver C / Holm, Lars / Scaife, Paula / Hansen, Rikke / Smith, Kenneth / Tipton, Kevin D / Mose, Maike / Bengtsen, Mads B / Lauritsen, Katrine M / Mikkelsen, Ulla R / Hansen, Mette

    The Journal of nutrition

    2023  Volume 153, Issue 11, Page(s) 3173–3184

    Abstract: Background: Diet-induced weight loss is associated with a decline in lean body mass, as mediated by an impaired response of muscle protein synthesis (MPS). The dose-response of MPS to ingested protein, with or without resistance exercise, is well ... ...

    Abstract Background: Diet-induced weight loss is associated with a decline in lean body mass, as mediated by an impaired response of muscle protein synthesis (MPS). The dose-response of MPS to ingested protein, with or without resistance exercise, is well characterized during energy balance but limited data exist under conditions of energy restriction in clinical populations.
    Objective: To determine the dose-response of MPS to ingested whey protein following short-term diet-induced energy restriction in overweight, postmenopausal, women at rest and postexercise.
    Design: Forty middle-aged (58.6±0.4 y), overweight (BMI: 28.6±0.4), postmenopausal women were randomly assigned to 1 of 4 groups: Three groups underwent 5 d of energy restriction (∼800 kcal/d). On day 6, participants performed a unilateral leg resistance exercise bout before ingesting either a bolus of 15g (ERW15, n = 10), 35g (ERW35, n = 10) or 60g (ERW60, n = 10) of whey protein. The fourth group (n = 10) ingested a 35g whey protein bolus after 5 d of an energy balanced diet (EBW35, n = 10). Myofibrillar fractional synthetic rate (FSR) was calculated under basal, fed (FED) and postexercise (FED-EX) conditions by combining an L-[ring-
    Results: Myofibrillar FSR was greater in ERW35 (0.043±0.003%/h, P = 0.013) and ERW60 (0.042±0.003%/h, P = 0.026) than ERW15 (0.032 ± 0.003%/h), with no differences between ERW35 and ERW60 (P = 1.000). Myofibrillar FSR was greater in FED (0.044 ± 0.003%/h, P < 0.001) and FED-EX (0.048 ± 0.003%/h, P < 0.001) than BASAL (0.027 ± 0.003%/h), but no differences were detected between FED and FED-EX (P = 0.732) conditions. No differences in myofibrillar FSR were observed between EBW35 (0.042 ± 0.003%/h) and ERW35 (0.043 ± 0.003%/h, P = 0.744).
    Conclusion: A 35 g dose of whey protein, ingested with or without resistance exercise, is sufficient to stimulate a maximal acute response of MPS following short-term energy restriction in overweight, postmenopausal women, and thus may provide a per serving protein recommendation to mitigate muscle loss during a weight loss program.
    Trial registry: clinicaltrials.gov (ID: NCT03326284).
    MeSH term(s) Middle Aged ; Humans ; Female ; Whey Proteins ; Overweight/metabolism ; Postmenopause ; Diet, Reducing ; Muscle, Skeletal/metabolism ; Muscle Proteins/metabolism ; Resistance Training
    Chemical Substances Whey Proteins ; Muscle Proteins
    Language English
    Publishing date 2023-08-19
    Publishing country United States
    Document type Randomized Controlled Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 218373-0
    ISSN 1541-6100 ; 0022-3166
    ISSN (online) 1541-6100
    ISSN 0022-3166
    DOI 10.1016/j.tjnut.2023.08.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Distribution of cholinergic nerve terminals in the aged human brain measured with [

    Okkels, Niels / Horsager, Jacob / Labrador-Espinosa, Miguel A / Hansen, Frederik O / Andersen, Katrine B / Just, Mie Kristine / Fedorova, Tatyana D / Skjærbæk, Casper / Munk, Ole L / Hansen, Kim V / Gottrup, Hanne / Hansen, Allan K / Grothe, Michel J / Borghammer, Per

    NeuroImage

    2023  Volume 269, Page(s) 119908

    Abstract: Introduction: [: Materials and methods: [: Results: Twenty participants of both sexes and a mean age of 73.9 ± 6.0 years, age-range [64; 86], were recruited. Highest tracer binding was present in the striatum, some thalamic nuclei, and the basal ... ...

    Abstract Introduction: [
    Materials and methods: [
    Results: Twenty participants of both sexes and a mean age of 73.9 ± 6.0 years, age-range [64; 86], were recruited. Highest tracer binding was present in the striatum, some thalamic nuclei, and the basal forebrain. Intermediate binding was found in most nuclei of the brainstem, thalamus, and hypothalamus; the vermis and flocculonodular lobe; and the hippocampus, amygdala, insula, cingulate, olfactory cortex, and Heschl's gyrus. Lowest binding was present in most areas of the cerebral cortex, and in the cerebellar nuclei and hemispheres. The spatial distribution of tracer correlated with immunohistochemical post-mortem data, as well as with regional expression levels of SLC18A3, the VAChT coding gene.
    Discussion: Our in vivo findings confirm the regional cholinergic distribution in specific brain structures as described post-mortem. A positive spatial correlation between tracer distribution and regional gene expression levels further corroborates [
    MeSH term(s) Aged ; Female ; Humans ; Male ; Middle Aged ; Brain/metabolism ; Cholinergic Agents ; Electrons ; Piperidines ; Positron-Emission Tomography/methods ; Vesicular Acetylcholine Transport Proteins/metabolism ; Fluorine Radioisotopes
    Chemical Substances Cholinergic Agents ; Piperidines ; Vesicular Acetylcholine Transport Proteins ; benzovesamicol ; Fluorine Radioisotopes
    Language English
    Publishing date 2023-01-29
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1147767-2
    ISSN 1095-9572 ; 1053-8119
    ISSN (online) 1095-9572
    ISSN 1053-8119
    DOI 10.1016/j.neuroimage.2023.119908
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top